- Home
- Genomes
- Genome Browser
- Tools
- Mirrors
- Downloads
- My Data
- Projects
- Help
- About Us
CXCL10 → Prolactin: " Prolactin enhances interferon-gamma induced production of CXC ligand 9 (CXCL9), CXCL10 , and CXCL11 in human keratinocytes "
CXCL11 → interferon-gamma: " Prolactin enhances interferon-gamma induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes "
CXCL11 → Prolactin: " Prolactin enhances interferon-gamma induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes "
CXCL10 → Prolactin: " Prolactin enhances interferon-gamma induced production of CXC ligand 9 (CXCL9), CXCL10 , and CXCL11 in human keratinocytes "
CXC ligand 9 (CXCL9) → interferon-gamma: " Prolactin enhances interferon-gamma induced production of CXC ligand 9 (CXCL9) , CXCL10, and CXCL11 in human keratinocytes "
CXCL10 — prolactin: " We examined in vitro effects of prolactin on CXCL9, CXCL10 , and CXCL11 production in human keratinocytes "
CXCL10 → IFN-gamma: " Although prolactin alone was ineffective, it enhanced IFN-gamma induced secretion and mRNA expression of CXCL9, CXCL10 , and CXCL11 in parallel to the activation of STAT1, NF-kappaB, and IRF-1 "
CXCL11 → IFN-gamma: " Although prolactin alone was ineffective, it enhanced IFN-gamma induced secretion and mRNA expression of CXCL9, CXCL10, and CXCL11 in parallel to the activation of STAT1, NF-kappaB, and IRF-1 "
CXCL9 → IFN-gamma: " Although prolactin alone was ineffective, it enhanced IFN-gamma induced secretion and mRNA expression of CXCL9 , CXCL10, and CXCL11 in parallel to the activation of STAT1, NF-kappaB, and IRF-1 "
CXCL10 → MAPK: " Inhibitors of Janus kinase ( JAK ), p38 MAPK , and MAPK/ERK kinase (MEK) suppressed prolactin- plus IFN-gamma induced CXCL9, CXCL10 , and CXCL11 production and NF-kappaB, STAT1, and IRF-1 activities "
CXCL10 → Janus kinase ( JAK ): " Inhibitors of Janus kinase ( JAK ) , p38 MAPK, and MAPK/ERK kinase (MEK) suppressed prolactin- plus IFN-gamma induced CXCL9, CXCL10 , and CXCL11 production and NF-kappaB, STAT1, and IRF-1 activities "
CXCL11 → MAPK: " Inhibitors of Janus kinase ( JAK ), p38 MAPK , and MAPK/ERK kinase (MEK) suppressed prolactin- plus IFN-gamma induced CXCL9, CXCL10, and CXCL11 production and NF-kappaB, STAT1, and IRF-1 activities "
CXCL11 → Janus kinase ( JAK ): " Inhibitors of Janus kinase ( JAK ) , p38 MAPK, and MAPK/ERK kinase (MEK) suppressed prolactin- plus IFN-gamma induced CXCL9, CXCL10, and CXCL11 production and NF-kappaB, STAT1, and IRF-1 activities "
STAT1 → MAPK: " Inhibitors of Janus kinase ( JAK ), p38 MAPK , and MAPK/ERK kinase (MEK) suppressed prolactin- plus IFN-gamma induced CXCL9, CXCL10, and CXCL11 production and NF-kappaB, STAT1 , and IRF-1 activities "
STAT1 → Janus kinase ( JAK ): " Inhibitors of Janus kinase ( JAK ) , p38 MAPK, and MAPK/ERK kinase (MEK) suppressed prolactin- plus IFN-gamma induced CXCL9, CXCL10, and CXCL11 production and NF-kappaB, STAT1 , and IRF-1 activities "
IRF-1 → MAPK: " Inhibitors of Janus kinase ( JAK ), p38 MAPK , and MAPK/ERK kinase (MEK) suppressed prolactin- plus IFN-gamma induced CXCL9, CXCL10, and CXCL11 production and NF-kappaB, STAT1, and IRF-1 activities "
IRF-1 → Janus kinase ( JAK ): " Inhibitors of Janus kinase ( JAK ) , p38 MAPK, and MAPK/ERK kinase (MEK) suppressed prolactin- plus IFN-gamma induced CXCL9, CXCL10, and CXCL11 production and NF-kappaB, STAT1, and IRF-1 activities "
CXCL9 → MAPK/ERK kinase (MEK): " Inhibitors of Janus kinase ( JAK ), p38 MAPK, and MAPK/ERK kinase (MEK) suppressed prolactin- plus IFN-gamma induced CXCL9 , CXCL10, and CXCL11 production and NF-kappaB, STAT1, and IRF-1 activities "
CXCL9 → IFN-gamma: " Inhibitors of Janus kinase ( JAK ), p38 MAPK, and MAPK/ERK kinase (MEK) suppressed prolactin- plus IFN-gamma induced CXCL9 , CXCL10, and CXCL11 production and NF-kappaB, STAT1, and IRF-1 activities "
CXCL9 → Janus kinase ( JAK ): " Inhibitors of Janus kinase ( JAK ) , p38 MAPK, and MAPK/ERK kinase (MEK) suppressed prolactin- plus IFN-gamma induced CXCL9 , CXCL10, and CXCL11 production and NF-kappaB, STAT1, and IRF-1 activities "
NF-kappaB → MAPK/ERK kinase (MEK): " Inhibitors of Janus kinase ( JAK ), p38 MAPK, and MAPK/ERK kinase (MEK) suppressed prolactin- plus IFN-gamma induced CXCL9, CXCL10, and CXCL11 production and NF-kappaB , STAT1, and IRF-1 activities "
NF-kappaB → Janus kinase ( JAK ): " Inhibitors of Janus kinase ( JAK ) , p38 MAPK, and MAPK/ERK kinase (MEK) suppressed prolactin- plus IFN-gamma induced CXCL9, CXCL10, and CXCL11 production and NF-kappaB , STAT1, and IRF-1 activities "
prolactin- → MAPK/ERK kinase (MEK): " Inhibitors of Janus kinase ( JAK ), p38 MAPK, and MAPK/ERK kinase (MEK) suppressed prolactin- plus IFN-gamma induced CXCL9, CXCL10, and CXCL11 production and NF-kappaB, STAT1, and IRF-1 activities "
prolactin- → Janus kinase ( JAK ): " Inhibitors of Janus kinase ( JAK ) , p38 MAPK, and MAPK/ERK kinase (MEK) suppressed prolactin- plus IFN-gamma induced CXCL9, CXCL10, and CXCL11 production and NF-kappaB, STAT1, and IRF-1 activities "
MAPK → IFN-gamma: " Prolactin induced phosphorylation of JAK2 and ERK, whereas IFN-gamma induced phosphorylation of JAK1, JAK2, and p38 MAPK "
ERK → MAPK: " Prolactin induced phosphorylation of JAK2 and ERK , whereas IFN-gamma induced phosphorylation of JAK1, JAK2, and p38 MAPK "
ERK → IFN-gamma: " Prolactin induced phosphorylation of JAK2 and ERK , whereas IFN-gamma induced phosphorylation of JAK1, JAK2, and p38 MAPK "
ERK → JAK1: " Prolactin induced phosphorylation of JAK2 and ERK , whereas IFN-gamma induced phosphorylation of JAK1 , JAK2, and p38 MAPK "
ERK → JAK2: " Prolactin induced phosphorylation of JAK2 and ERK , whereas IFN-gamma induced phosphorylation of JAK1, JAK2 , and p38 MAPK "
ERK → Prolactin: " Prolactin induced phosphorylation of JAK2 and ERK , whereas IFN-gamma induced phosphorylation of JAK1, JAK2, and p38 MAPK "
IFN-gamma → JAK1: " Prolactin induced phosphorylation of JAK2 and ERK, whereas IFN-gamma induced phosphorylation of JAK1 , JAK2, and p38 MAPK "
IFN-gamma → JAK2: " Prolactin induced phosphorylation of JAK2 and ERK, whereas IFN-gamma induced phosphorylation of JAK1, JAK2 , and p38 MAPK "
JAK2 → MAPK: " Prolactin induced phosphorylation of JAK2 and ERK, whereas IFN-gamma induced phosphorylation of JAK1, JAK2, and p38 MAPK "
JAK2 → JAK1: " Prolactin induced phosphorylation of JAK2 and ERK, whereas IFN-gamma induced phosphorylation of JAK1 , JAK2, and p38 MAPK "
JAK2 → JAK2: " Prolactin induced phosphorylation of JAK2 and ERK, whereas IFN-gamma induced phosphorylation of JAK1, JAK2 , and p38 MAPK "
JAK2 → Prolactin: " Prolactin induced phosphorylation of JAK2 and ERK, whereas IFN-gamma induced phosphorylation of JAK1, JAK2, and p38 MAPK "
Prolactin → MAPK: " Prolactin induced phosphorylation of JAK2 and ERK, whereas IFN-gamma induced phosphorylation of JAK1, JAK2, and p38 MAPK "
Prolactin → IFN-gamma: " Prolactin induced phosphorylation of JAK2 and ERK, whereas IFN-gamma induced phosphorylation of JAK1, JAK2, and p38 MAPK "
Prolactin → JAK1: " Prolactin induced phosphorylation of JAK2 and ERK, whereas IFN-gamma induced phosphorylation of JAK1 , JAK2, and p38 MAPK "
Prolactin → JAK2: " Prolactin induced phosphorylation of JAK2 and ERK, whereas IFN-gamma induced phosphorylation of JAK1, JAK2 , and p38 MAPK "
STAT1 → IFN-gamma: " Prolactin modestly or IFN-gamma greatly induced tyrosine phosphorylation of STAT1 , and both were suppressed by JAK inhibitor "
STAT1 → JAK: " Prolactin modestly or IFN-gamma greatly induced tyrosine phosphorylation of STAT1 , and both were suppressed by JAK inhibitor "
IFN-gamma → JAK: " Prolactin modestly or IFN-gamma greatly induced tyrosine phosphorylation of STAT1, and both were suppressed by JAK inhibitor "
STAT1 → IFN-gamma: " Prolactin modestly or IFN-gamma greatly induced serine phosphorylation of STAT1 , which was suppressed by MEK or p38 MAPK inhibitor, respectively "
p65 → Prolactin: " Prolactin induced phosphorylation of inhibitory kappaBalpha and NF-kappaB p65 , which was suppressed by MEK inhibitor "
CXCL10 → IFN-gamma: " These results suggest that prolactin may enhance IFN-gamma induced CXCL9, CXCL10 , and CXCL11 production in keratinocytes via activation of STAT1, NF-kappaB, and IRF-1 through JAK2 and MEK/ERK pathways "
CXCL10 → prolactin: " These results suggest that prolactin may enhance IFN-gamma induced CXCL9, CXCL10 , and CXCL11 production in keratinocytes via activation of STAT1, NF-kappaB, and IRF-1 through JAK2 and MEK/ERK pathways "
CXCL10 → prolactin: " These results suggest that prolactin may enhance IFN-gamma induced CXCL9, CXCL10 , and CXCL11 production in keratinocytes via activation of STAT1, NF-kappaB, and IRF-1 through JAK2 and MEK/ERK pathways "